Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma

British Journal of Dermatology

Volumn 171, Issue 3, 2014, Pages 499-504

  Cetinozman F ^a   Jansen, P M ^a   Willemze, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD2 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CXCL13 CHEMOKINE; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN BCL 6; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ARTICLE; ATOPIC ERYTHRODERMA; BLAST CELL; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DERMIS; EOSINOPHIL; EPIDERMIS; ERYTHRODERMA; ERYTHRODERMIC PSORIASIS; HUMAN; HUMAN TISSUE; IDIOPATHIC ERYTHRODERMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PARANEOPLASTIC ERYTHRODERMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ERYTHRODERMA; SEZARY SYNDROME; SKIN BIOPSY; T LYMPHOCYTE; BIOPSY; DERMATITIS, EXFOLIATIVE; DIFFERENTIAL DIAGNOSIS; METABOLISM; PARANEOPLASTIC SYNDROMES; PATHOLOGY; PSORIASIS; SKIN; SKIN NEOPLASMS;

BIOLOGICAL MARKERS; BIOPSY; DERMATITIS, EXFOLIATIVE; DIAGNOSIS, DIFFERENTIAL; HUMANS; PARANEOPLASTIC SYNDROMES; PROGRAMMED CELL DEATH 1 RECEPTOR; PSORIASIS; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 84925247119     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12934     Document Type: Article

References (16)

1. Fife BT, Pauken KE,. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci 2011; 1217: 45-59.
2. Francisco LM, Sage PT, Sharpe AH,. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236: 219-42.
3. Roncador G, Garcia Verdes-Montenegro JF, Tedoldi S, et al,. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007; 92: 1059-66.
4. Rodriguez-Pinilla SM, Atienza L, Murillo C, et al,. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol 2008; 32: 1787-99.
5. + small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009; 33: 81-90.
6. Cetinozman F, Jansen PM, Willemze R,. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol 2012; 36: 109-16.
7. + small/medium pleomorphic T-cell lymphoma and dermatitis. J Cutan Pathol 2013; 40: 1006-13.
8. Cetinozman F, Jansen PM, Vermeer MH, et al,. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides. Arch Dermatol 2012; 148: 1379-85.
9. Wada DA, Wilcox RA, Harrington SM, et al,. Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome. Am J Hematol 2011; 86: 325-7.
10. Kantekure K, Yang Y, Raghunath P, et al,. Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides. Am J Dermatopathol 2012; 34: 126-8.
11. Ram-Wolff C, Martin-Garcia N, Bensussan A, et al,. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies. Am J Dermatopathol 2010; 32: 755-63.
12. Willemze R, Jaffe ES, Burg G, et al,. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
13. Sentis HJ, Willemze R, Scheffer E,. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 1986; 15: 1217-26.
14. Diwan AH, Prieto VG, Herling M, et al,. Primary Sézary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol 2005; 123: 510-15.
15. Alaibac M, Pigozzi B, Belloni-Fortina A, et al,. CD7 expression in reactive and malignant human skin T-lymphocytes. Anticancer Res 2003; 23: 2707-10.
16. Florell SR, Cessna M, Lundell RB, et al,. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol 2006; 125: 727-36.